The nice people at Transfusion News
sent their update today. It was rather COVID-19 focussed, but that is the world
of today…
COVID-19 Convalescent Plasma Provides More than Neutralizing Antibodies
 |
|
September 30, 2020 |
|
With few drugs to combat SARS-CoV-2 infections and the approval from the
U.S. FDA for Emergency Use Authorization of COVID-19 convalescent
plasma (CCP), many patients are now receiving CCP. In order to gain a
better understanding of the antiviral properties of CCP, researchers
profiled 126 plasma samples from eligible convalescent donors using an
Fc array assay customized for [Read More] |
|
 |
In response to demands for a reliable and effective serological test for
COVID-19, Bio-Rad now offers the Platelia SARS-CoV-2 Total Ab assay for
the detection of total antibodies (IgM, IgA and IgG) to SARS-CoV-2, the
virus associated with COVID-19.
This blood-based immunoassay was designed for identifying people who
have been exposed to SARS-CoV-2. Providing total antibody detection
(IgM, IgA, IgG) in just one test, the assay has been validated on
Bio-Rad EVOLIS Instruments and can also be run using manual and
automated, high-volume testing protocols. [Click for more] |
|
|
September 22, 2020 |
|
In order to gain a better understanding of SARS-CoV-2 seroprevalence,
the American Red Cross tested all blood donations from June 15, 2020 to
August 23, 2020 for anti-SARS-CoV-2 IgG. Of the 953,926 donations
collected, 17,336 (1.82%) were positive for SARS-CoV-2 antibodies.
Almost 3% (N=4786) of first-time donors were [Read More] |
No comments:
Post a Comment